Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
4 hedge funds and large institutions have $1.04M invested in Kitov Pharma Ltd. Warrants in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
198% more capital invested
Capital invested by funds: $350K → $1.04M (+$694K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.62M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$2.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$95.5K |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.02K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5K |
KTOVW Hedge Fund Activity: Q2 2016 in Review
4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q2 2016, worth a combined $1.04M — up 198% from $350K a quarter earlier.
Fund positioning in KTOVW was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, adding an estimated $1.62M. The largest seller was Ionic Capital Management, cutting an estimated $95.5K.
- 4 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $1.04M of Kitov Pharma Ltd. Warrants stock for Q2 2016, up 198% quarter-over-quarter.
- 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q2 2016 and 1 closed out, a net change of 0 holders.
- The largest Kitov Pharma Ltd. Warrants buyer in Q2 2016 was Sabby Management, an estimated $1.62M added.
- The largest Kitov Pharma Ltd. Warrants seller in Q2 2016 was Ionic Capital Management, an estimated $95.5K sold.
Based on aggregated 13F filings for Q2 2016.